“We believe that the spinal implants business, with its comprehensive portfolio and strong sales channel, will thrive as an ...

Lake Street analyst Brooks O’Neil notes that Stryker (SYK) announced a definitive agreement for the sale of its U.S. spinal implants business ...

Wall Street analysts upgraded Stryker Corp (NYSE: SYK) after its Q4 report beat expectations, with strong sales and earnings ...

Stryker Corporation (NYSE:SYK), a leading player in the medical technology industry with a substantial market capitalization of $149 billion, has been making waves with its strong financial ...

Stryker reported goodwill and other impairments of $818 million related to the spine business in the fourth quarter.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Stryker is selling off its spine implant business—starting with a plan to spin off its U.S. operations before moving on to ...

Goldman Sachs raised the firm’s price target on Stryker (SYK) to $427 from $384 and keeps a Neutral rating on the shares after its Q4 earnings ...

Shares of Stryker Corp. SYK slid 1.03% to $391.07 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 0.47% to 6,039.31 and Dow ...

Stryker is selling its U.S. spinal implant business to investment firm Viscogliosi Brothers, a move that is expected to help the company ...

The US is urging India to ramp up military purchases, with defence sales exceeding $25 billion since 2007. As both countries ...